英文論文（２０１３年）　

※ in press、Epub ahead of printは含めておりません。

  1. Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Dong Y, Takashina S, Kanda A, Noda M, Noda K, Ishida S. Expression of alphaB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. Anticancer Res. 2013; 33: 3745-3751
  2. Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization.  Mol Vis. 2013; 19: 536-543
  3. Fukuhara J, Kase S, Ohashi T, Ando R, Dong Z, Noda K, Ohguchi T, Kanda A, Ishida S. Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol. 2013; 139: 381-389
  4. Fukuhara J, Noda K, Murata M, Namba S, Kinoshita S, Dong Z, Ando R, Lennikov A, Kanda A, Ishida S. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2013; 54: 274-279
  5. Hiraoka M, Abe A, Lennikov A, Kitaichi N, Ishida S, Ohguro H. Increase of lysosomal phospholipase A2 in aqueous humor by uveitis. Exp Eye Res. 2013; 118: 13-19
  6. Hirooka K, Saito W, Noda K, Ishida S. A patient with acute macular neuroretinopathy and central retinal vein occlusion. Clin Ophthalmol. 2013; 7: 1447-1450
  7. Iwahashi –Shima C, Azumi A, Ohguro N, Okada A. A, Kaburaki T, Goto H, Sonoda K, Namba K, Mizuki N, Mochizuki M. Acute retinal necrosis: factors associated with anatomic and visual outcomes. Jpn J Ophthalmol. 2013; 57: 98-103
  8. Jin XH, Namba K, Saito W, Iwata D, Ishida S. Bacterial endophthalmitis caused by an intraocular cilium in a patient under treatment with infliximab. J Ophthalmic Inflamm and Infect. 2013; 3:50
  9. Kanda A, Noda K, Saito W, Ishida S. Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol. 2013; 97: 666-668
  10. Kanda A, Noda K, Yuki K, Ozawa Y, Furukawa T, Ichihara A, Ishida S. Atp6ap2/(pro)renin receptor interacts with Par3 as a cell polarity determinant required for laminar formation during retinal development in mice. J Neurosci. 2013; 33: 19341-19351
  11. Kase S, Namba K, Kitaichi N, Iwata D, Ohno S, Ishida S. Clinical features of human T lymphotropic virus type-1 associated uveitis in Hokkaido, Japan. Jpn J Ophthalmol. 2013; 57: 379-384
  12. Kase S, Noda M, Ishijima K, Yamamoto T, Hatanaka K, Ishida S. IgG4-related inflammation of the orbit simulating malignant lymphoma. Anticancer Res. 2013; 33: 2779-2783
  13. Kase S, Rao NA, Yoshikawa H, Fukuhara J, Noda K, Kanda A, Ishida S. Expression of vascular endothelial growth factor in eyes with Coats disease. Invest Ophthalmol Vis Sci. 2013; 54: 57-62
  14. Kase S, Yamamoto T, Ishijima K, Noda M, Ishida S. Spontaneous regression of IgG4-related dacryoadenitis. Mod Rheumatol. 2013; 23: 1018-1021
  15. Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Song R, Kang YM, Kang SW, Baek HJ, Kitaichi N, Meguro A, Mizuki N, Namba K, Ishida S, Kim J, Niemczek E, Lee EY, Song YW, Ohno S, Lee EB. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet’s disease. Ann Rheum Dis. 2013; 72: 1510-1516
  16. Lennikov A, Kitaichi N, Kase S, Noda K, Horie Y, Nakai A, Ohno S, Ishida S. Induction of heat shock protein 70 ameliorates ultraviolet-induced photokeratitis in mice. Int J Mol Sci. 2013; 2175-2189
  17. Mizuuchi K, Kitaichi N, Namba K, Horie Y, Ishida S, Ohno S. Trabecular meshwork depigmentation in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2013; 57: 245-251
  18. Ohguchi T, Kojima T, Ibrahim OM, Nagata T, Shimizu T, Shirasawa T, Kawakita T, Satake Y, Tsubota K, Shimazaki J, Ishida S. The effects of 2% rebapimide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (Sod1) knockout mice. Invest Ophthalmol Vis Sci. 2013; 54: 7793-7802
  19. Ozeki N, Shinoda K, Ohde H, Ishida S, Tsubota K. Improvement of visual acuity after transcorneal electrical stimulation in case of Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2013; 251:1867-1870 
  20. Saito M, Saito W, Hashimoto Y, Yoshizawa C, Fujiya A, Noda K, Ishida S. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol. 2013; 97: 775-780
  21. Saito N, Yoshioka N, Abe R, Qiao H, Fujita Y, Hoshina D, Kase S, Kitaichi N, Ozaki M, Shimizu H. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using of PBMCs and the skin of patients. J Allergy Clin Immunol. 2013; 131: 434-441
  22. Saito W, Kase S, Fujiya A, Dong Z, Noda K, Ishida S. Expression of vascular endothelial growth factor (VEGF) and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Retina. 2013; 33: 1959-1967
  23. Saito W, Kase S, Ohguro H, Ishida S. Autoimmune retinopathy associated with colonic adenoma. Graefes Arch Clin Exp Ophthalmol. 2013; 251: 1447-1449
  24. Takashina S, Saito W, Noda K, Katai M, Ishida S. Membrane tissue on the optic disc may cause macular schisis associated with a glaucomatous optic disc without optic disc pits. Clin Ophthalmol. 2013; 7: 883-887
  25. Takemoto Y, Namba K, Mizuuchi K, Ohno S, Ishida S. Two cases of subfoveal choroidal neovascularization with tubulointerstitial nephritis and uveitis (TINU) syndrome. Eur J Ophthalmol. 2013; 23: 255-257
  26. Terasaki H, Kase S, Shirasawa M, Otsuka H, Sonoda S, Ishida S, Sakamoto T. TNF-α decreases VEGF secretion in highly polarized RPE cells but increases it in non-polarized RPE cells related to crosstalk between JNK and NF-κB pathways. PLOS One. 2013; 8: e69994
  27. Uchida A, Shinoda K, Matsumoto CS, Kawai M, Kawai S, Ohde H, Ozawa Y, Ishida S, Inoue M, Mizota A, Tsubota K. Acute visual field defect following vitrectomy determined to originate from optic nerve by electrophysiological tests. Case Rep Ophthalmol. 2012;3:396-405（2012記載漏れ）
  28. Yaguchi S, Ogawa Y, Shimmura S, Kawakita T, Hatou S, Satofuka S, Nakamura S, Imada T, Miyashita H, Yoshida S, Yaguchi T, Ozawa Y, Mori T, Okamoto S, Kawakami Y, Ishida S, Tsubota K. Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease. PLoS One. 2013; 8: e64724
  29. Yamamoto T, Kuwayama Y, Kano K, Sawada A, Shoji N, Chin S, Shinmei Y, Nitta T. Clinical features of bleb-related infection: a 5-year survey in Japan. Acta Ophthalmologica. 2012:1-6（2012記載漏れ）
  30. Yamamoto T, Kuwayama Y, Kano K, Sawada A, Shoji N, Chin S, Shinmei Y, Nitta T, for the Study Group for the Japan Glaucoma Society Survey of Bleb-related Infection. Clinical features of bleb-related infection: a 5-year survey in Japan. Acta Ophthalmologica. 2013; 91: 619-624
  31. Yamamoto T, Kuwayama Y, Nomura E, Tanihara H, Mori K, Chin S, Shinmei Y, Nitta T. Changes in visual acuity and intra-ocular pressure following bleb-related infection : the Japan glaucoma society survey of bleb-related infection report 2. Acta Ophthalmologica. 2013:1-6
  32. Yamane S, Lee A, Hanaoka N, Gonzalez G, Kaneko H, Ishida S, Kitaichi N, Ohno S, Koyanagi K, Aoki K, Fujimoto T, Yawata N, Watanabe H. Identification of contamination in the American Type Culture Collection stock of human adenovirus type 8 by whole genome sequencing. J Virol. 2013; 87: 1285-1286
  33. Yoshikawa N, Noda K, Ozawa Y, Mashima Y, Ishida S. Blockade for vascular adhesion protein-1 suppresses pathological neovascularization in oxygen-induced retinopathy. Acta Ophthalmol. 2013; e409-e410
  34. Yoshikawa N, Noda K, Shinoda H, Uchida A, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type Ⅱ diabetes. J Diabetes Complications. 2013; 27: 162-166
  35. Yoshizawa C, Saito W, Hirose S, Kitamei H, Noda K, Ishida S. Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Jpn J Ophthalmol. 2013; 57: 68-73